logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
For ProvidersRequest DemoJoin Research Panel
Prescribing toolsPrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyPartnershipsAboutCareersContact Us
Get the latest insights in your inbox
  • Terms and Conditions
  • Privacy Policy
  • © 2026 PrescriberPoint. All Rights Reserved.
    1. Home
    2. Indications
    3. Bipolar I Disorder Most Recent Episode Depression

    Medications for Bipolar I Disorder Most Recent Episode Depression

    FiltersReset Filters
    6 results

    • latuda

      (lurasidone hydrochloride)
      Sumitomo Pharma America, Inc.
      Usage: LATUDA is indicated for the treatment of schizophrenia in patients aged 13-17, monotherapy for bipolar depression in those aged 10-17, and as adjunctive treatment with lithium or valproate for adult patients with bipolar depression.

    • lurasidone hydrochloride

      (Lurasidone Hydrochloride)
      Golden State Medical Supply, Inc.
      Usage: Lurasidone hydrochloride is indicated for the treatment of schizophrenia in adults and adolescents (13-17 years), and for monotherapy or adjunctive treatment in patients (10-17 years) with major depressive episodes associated with bipolar I disorder.

    • olanzapine

      (Olanzapine)
      Ascend Laboratories, LLC
      Usage: Oral olanzapine is indicated for treating schizophrenia, bipolar I disorder (manic or mixed episodes), and as an adjunct to lithium or valproate for bipolar I disorder. It is also used in combination with fluoxetine for depressive episodes associated with bipolar I disorder and treatment-resistant depression.

    • olanzapine

      (Olanzapine)
      Teva Pharmaceuticals USA, Inc.
      Usage: Olanzapine orally disintegrating tablets are indicated for treating schizophrenia, bipolar I disorder (including manic or mixed episodes), and depressive episodes associated with bipolar I when combined with fluoxetine. Pediatric use requires careful consideration of risks. Monotherapy for depressive episodes and treatment-resistant depression is not indicated.

    • olanzapine

      (Olanzapine)
      Upsher-Smith Laboratories, LLC
      Usage: Olanzapine is indicated for treating schizophrenia, bipolar I disorder (both manic/mixed episodes and maintenance), depressive episodes associated with bipolar I disorder (in combination with fluoxetine), and treatment-resistant depression (also in combination). Cautions exist for pediatric use due to risks like weight gain and dyslipidemia.

    • vraylar

      (cariprazine)
      Allergan, Inc.
      Usage: VRAYLAR® is indicated for the treatment of schizophrenia, acute manic or mixed episodes associated with bipolar I disorder, depressive episodes in bipolar I disorder, and as adjunctive therapy to antidepressants for major depressive disorder in adults.